Evidence Summary

Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions

November 07, 2023

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

By Roger Chou, MD; Christina Bougatsos, MPH; Jessica Griffin, MS; Shelley S. Selph, MD, MPH; Azrah Ahmed, BA; Rongwei Fu, PhD; Chad Nix, MSc; Eli Schwarz, DDS, MPH, PhD

The information in this article is intended to help clinicians, employers, policymakers, and others make informed decisions about the provision of health care services. This article is intended as a reference and not as a substitute for clinical judgment.

This article may be used, in whole or in part, as the basis for the development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

This article was published online in JAMA on November 7, 2023 (JAMA. 2023;330(17):1674-1686. doi:10.1001/jama.2023.20).

Return to Table of Contents

Importance: Dental caries is common in children and adolescents aged 5 to 17 years and potentially amenable to primary care screening and prevention.

Objective: To systematically review the evidence on primary care screening and prevention of dental caries in children and adolescents aged 5 to 17 years to inform the US Preventive Services Task Force.

Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews (to October 3, 2022); surveillance through July 21, 2023.

Study Selection: Diagnostic accuracy of primary care screening instruments and oral examination; randomized and nonrandomized trials of screening and preventive interventions and systematic reviews of such studies; cohort studies on primary care oral health screening and preventive intervention harms.

Data Extraction and Synthesis: One investigator abstracted data; a second checked accuracy. Two investigators independently rated study quality. Random-effects meta-analysis was performed for fluoride supplements and xylitol; for other preventive interventions, pooled estimates were used from good-quality systematic reviews.

Main Outcomes and Measures: Dental caries, morbidity, functional status, quality of life, harms; diagnostic test accuracy.

Results: Three systematic reviews (total 20,684 participants) and 19 randomized clinical trials, 3 nonrandomized trials, and 1 observational study (total 15,026 participants) were included. No study compared screening vs no screening. When administered by dental professionals or in school settings, fluoride supplements compared with placebo or no intervention were associated with decreased change from baseline in the number of decayed, missing, or filled permanent teeth (DMFT index) or decayed or filled permanent teeth (DFT index) (mean difference, −0.73 [95% CI, −1.30 to −0.19]) at 1.5 to 3 years (6 trials; n = 1395). Fluoride gels were associated with a DMFT- or DFT-prevented fraction of 0.18 (95% CI, 0.09-0.27) at outcomes closest to 3 years (4 trials; n = 1525), fluoride varnish was associated with a DMFT- or DFT-prevented fraction of 0.44 (95% CI, 0.11-0.76) at 1 to 4.5 years (5 trials; n = 3902), and resin-based sealants were associated with decreased risk of carious first molars (odds ratio, 0.21 [95% CI, 0.16-0.28]) at 48 to 54 months (4 trials; n = 440). No trial evaluated primary care counseling or dental referral. Evidence on screening accuracy, silver diamine fluoride, xylitol, and harms was very limited, although serious harms were not reported.

Conclusions and Relevance: Administration of fluoride supplements, fluoride gels, varnish, and sealants in dental or school settings improved caries outcomes. Research is needed on the effectiveness of oral health preventive interventions in primary care settings and to determine the benefits and harms of screening.

Return to Table of Contents

Oral health issues, most commonly due to dental caries, are common in children and adolescents and are often untreated.1 Dental caries can lead to pain, disability, and decreased well-being.2-5 Gaps exist in the provision of oral health services in school-aged children6 and include disparities related to race and ethnicity, socioeconomic status, and other factors.1,7 In school-aged children and adolescents, oral health screening and preventive interventions could potentially be provided in primary care settings and reduce associated negative health consequences and disparities. This evidence report was conducted to inform the US Preventive Services Task Force (USPSTF) for a new recommendation on primary care screening, dental referral, behavioral counseling, and preventive interventions for oral health in children and adolescents aged 5 to 17 years. This report does not address school or community-based oral health interventions,8 which are outside the USPSTF’s scope. A complementary evidence report was conducted for the USPSTF on oral health screening and prevention in adults;9 the USPSTF addressed oral cancer screening separately10 and previously addressed screening and prevention of dental caries in children younger than 5 years.11,12

Return to Table of Contents

Scope of Review

Detailed methods and evidence tables with additional study details are available in the full evidence report.13 Figure 1 and Figure 2 show the analytic frameworks and key questions (KQs) that guided the review. Separate analytic frameworks were used to distinguish treatment of children and adolescents with existing dental caries or periodontal disease (screening) from treatment of those without those conditions (preventive interventions). The full report13 includes findings for contextual questions (not systematically reviewed) on the association between dental caries and long-term health outcomes, oral health disparities, and primary care interventions to reduce disparities. In addition, this article focuses on results from 2 fair-quality trials of xylitol;15,16 results of 8 poor-quality xylitol trials are described in the full report.13

Search Strategies

A research librarian searched MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews from inception to October 3, 2022 (eMethods 1 in the JAMA Supplement). Searches were supplemented by reference list review of relevant articles. Since October 3, 2022, ongoing surveillance was conducted through article alerts and targeted searches of journals to identify major studies published in the interim that could affect the conclusions or understanding of the evidence and the related USPSTF recommendation. The last surveillance was conducted on July 21, 2023, and identified no eligible randomized trials.

Study Selection

Two investigators independently reviewed titles, abstracts, and full-text articles using predefined eligibility criteria (eMethods 2 in the JAMA  Supplement). The population was asymptomatic children and adolescents aged 5 to 17 years who were not selected on the basis of having existing dental caries. Screening and diagnostic accuracy studies conducted in primary care settings of oral health examination or risk assessment instruments were eligible. Studies of risk instruments not administered in primary care settings were also eligible if they were relevant to primary care (ie, did not involve a dental professional examination or specialty tests). Eligible preventive interventions were primary care oral health behavioral counseling, referral to a dental professional, and preventive medications potentially feasible for primary care administration (not requiring extensive dental training): topical fluoride (varnish, foam, or gel), silver diamine fluoride (SDF) topical solution, dental sealants, and xylitol. Comparisons were against placebo or no intervention.

The most commonly reported outcome was dental caries (incidence or caries burden, often measured as the number of decayed, missing, or filled permanent teeth [DMFT index] or surfaces [DMFS index]; decayed or filled teeth [DFT] or surfaces [DFS] were also used in children because missing permanent teeth were less common and might not be due to caries). Other outcomes included periodontal disease presence and severity, morbidity, quality of life, functional status, and harms. Randomized or nonrandomized trials and diagnostic accuracy studies were eligible; cohort studies were also eligible for screening and preventive intervention harms.

Data Abstraction and Quality Rating

One investigator abstracted details about the study design, patient population, setting, interventions or screening instruments, analysis, follow-up, and results from each study. A second investigator reviewed abstracted data for accuracy. Two independent investigators assessed the quality of each study as good, fair, or poor using predefined criteria developed by the USPSTF (eMethods 3 in the JAMA Supplement). Discrepancies were resolved by consensus. In accordance with the USPSTF Procedure Manual,14 studies rated poor quality were included only if higher-quality evidence was unavailable.

Data Synthesis

For all KQs, the overall quality of evidence was rated as “good,” “fair,” or “poor” based on study limitations, consistency, precision, reporting bias, and applicability, using the approach described in the USPSTF Procedure Manual.14

Meta-analyses of oral health preventive interventions from high-quality systematic reviews were reported when available. Systematic reviews measured caries burden based on the prevented fraction (caries index in control group minus intervention group, divided by the control group caries index) or (for sealants) likelihood of first carious molars. For fluoride supplements, which lacked high-quality systematic reviews, profile likelihood model random-effects meta-analysis using Stata/SE version 16.1 (StataCorp)was performed to summarize effects on caries burden, based on the difference in DMFT or DFT increment (ie, difference in change from baseline to follow-up between treatment vs placebo or no treatment in the DMFT or DFT index; see eMethods4 in the JAMA Supplement for detailed meta-analytic methods). Analyses were conducted stratifying on relevant factors, including placebo or no treatment control; school or home setting; follow-up less than 3 years or 3 years or more; Europe or Canada vs other geographic region; high or low baseline caries burden; age 10 years or older or younger than 10 years; and study quality. All significance testing was 2-tailed; P values of .05 or less were considered statistically significant. Assessment for small study effects was not performed because the meta-analyses had fewer than 10 studies.17

Return to Table of Contents

Across all KQs, 3 systematic reviews18-20 (total of 20,684 participants) of 54 unique trials (53 publications)21-73 and 23 additional studies (in 27 publications;15,16,74-98 total of 15,026 participants) were included (Figure 3). One study assessed diagnostic accuracy of screening;74 the systematic reviews18-20 and other 22 studies (19 randomized clinical trials15,16,75-91 and 3 nonrandomized trials92-94) addressed preventive interventions.

Screening

Key Question 1. How effective is screening for oral health performed by a primary care clinician in preventing negative oral health outcomes?

No study addressed this KQ.

Key Question 2a. How accurate is screening for oral health performed by a primary care clinician in identifying children and adolescents who have oral health issues?

For identification of untreated caries in children aged 5 to 12 years, 1 fair-quality study74 found visual screening by a registered nurse (n = 219) following 5 hours of training associated with sensitivity of 0.92 (95% CI, 0.84-0.97) and specificity of 0.993 (95% CI, 0.96-0.9998), and a 17-item questionnaire completed by children’s parents or guardians (n = 305) associated with sensitivity of 0.69 (95% CI, 0.60-0.77) and specificity of 0.88 (95% CI, 0.83- 0.93) (eTables 1 and 2 in the JAMA Supplement). The reference standard was a full dentist examination.

Key Question 2b. How accurate is screening for oral health performed by a primary care clinician in identifying children and adolescents who are at increased risk for future oral health issues?

No study addressed this KQ.

Key Question 3. What are the harms of screening for oral health performed by a primary care clinician?

No study addressed this KQ.

Prevention

Key Question 1. How accurate is screening performed by a primary care clinician in identifying children and adolescents who are at increased risk of future oral health issues?

No study addressed this KQ.

Key Question 2. How effective is oral health behavioral counseling provided by a primary care clinician in preventing oral health issues?

No study addressed this KQ.

Key Question 3. How effective is referral by a primary care clinician to a dental health care provider in preventing oral health issues?

No study addressed this KQ.

Key Question 4. How effective are preventive interventions in preventing oral health issues?

Fluoride Supplements

Seven fair-quality trials (reported in 8 publications; n = 3382) evaluated fluoride supplements vs placebo or no supplement in children 5 years or older in settings with low socioeconomic status, nonfluoridated water, or high caries burden (eTables 3 and 4 in the JAMA Supplement).75-81,95 Trials were conducted in the US (3 studies), the UK (3 studies), and Taiwan (1 study). All trials recruited children from schools and were published before 1990 except for 1 (published in 2013).79 Fluoride supplements were administered daily as acidulated phosphate fluoride or sodium fluoride tablets. In 1 trial of older children (mean age, 12.5 years),76 fluoride supplements were taken at home; all other trials evaluated supervised supplement administration at school. All trials had unclear randomization and allocation concealment methods and were rated fair quality. Other methodological limitations included open-label design and high attrition.

Fluoride supplements were associated with a decreased DMFT or DFT increment compared with placebo or no supplement at 1.5 to 3 years (6 trials; effective n = 1395; mean difference, −0.73 [95% CI, −1.30 to −0.19]) (eFigure 1 in the JAMA Supplement); however, statistical heterogeneity was substantial (I2 = 80%).75-81,95 In a stratified analysis, supplements were not associated with reduced DMFT/DFT increment in 1 trial76 of home administration in adolescents that reported low adherence (n = 178; mean difference, 0.13 [95% CI −0.38 to 0.64]), but all school-administered trials reported reduced DMFT/DFT increment (5 trials; effective n = 1217; pooled mean difference, −0.88 [95% CI, −1.43 to −0.40]; I2 = 74%; P = .15 for interaction) (eFigure 2 in the JAMA Supplement). There were no statistically significant interactions between control type, follow-up duration, or age and effects of supplements on DMFT/DFT increment, although analyses were limited by small numbers of trials (eTable 5 in the JAMA Supplement).

Fluoride Gel

A good-quality systematic review18 (searches through November 2014) included 26 randomized or quasi-randomized trials (in 25 publications)21-45 of fluoride gels vs placebo or no treatment in children 5 years or older (n = 8619) (eTables 6 and 7 in the JAMA Supplement). Baseline age and caries burden varied, and reporting of fluoride exposure, socioeconomic status, and provision of oral health education was suboptimal. Twelve trials were conducted in the US, 6 trials in Europe, 4 in Brazil, and 1 each in Canada, Israel, China, and Venezuela. Five trials were published from 1990 to 2005; the other trials were published between 1967 and 1988.

Fluoride gel was most commonly administered as acidulated phosphate fluoride (12,300 ppm F). Gels were applied in dental clinics or schools using a tray (19 trials), brush (6 trials), or floss (1 trial). In 15 trials, gels were applied by a dental professional (1-4 times per year) and in 11 trials, gels were self-applied (mostly 5 times per year) with dental hygienist or other adult supervision. Only 1 trial was assessed as low risk of bias.44 Methodological limitations in the other trials included use of a quasi-randomized design (7 trials),21,22,29,31-33,38 unclear randomization or allocation concealment methods (19 trials), open-label design (10 trials), and high attrition (14 trials).

The systematic review found fluoride gels associated with reduced caries burden compared with no intervention or control based on a DMFT/DFT-prevented fraction of 0.32 (95% CI, 0.19-0.46) at outcomes closest to 3 years (10 trials; n = 3198). There was marked statistical heterogeneity (I2 = 91%), with estimates that varied by control type (placebo control–prevented fraction, 0.18 [95% CI, 0.09-0.27]; I2 = 6%; 4 trials; n = 1525; no treatment control–prevented fraction, 0.43 [95% CI, 0.29-0.57]; I2 = 90%; 6 trials; n = 1673).The systematic review found no statistically significant interactions between baseline caries level, exposure to fluoride, application method, application frequency, gel concentration, or follow-up duration and effects of gels. A supplemental analysis of data reported in the systematic review found similar estimates when children were stratified by baseline age younger than 10 years or 10 years or older (eFigure 3 in the JAMA Supplement). One subsequent good-quality trial82 (n = 986) reported results consistent with the systematic review (eTables 8 and 9 in the JAMA  Supplement).

Fluoride Varnish

A good-quality systematic review19 (searches through May 2013) included 14 trials46-59 of fluoride varnish vs placebo or no varnish in children 5 years or older (n = 6965) (eTables 10 and 11 in the JAMA Supplement). Baseline age, caries burden, and fluoride exposure varied. Eight trials were conducted in Europe, 2 trials each in Brazil and India, and 1 trial each in Canada and China. Four trials were published prior to 1990, 3 between 1990 and 1997, and 7 between 2005 and 2012. Fluoride varnish was most commonly administered as 5% sodium fluoride varnish (22,600 ppm) every 6 months. In all trials, varnish was applied by dental professionals in schools or local clinics. Ten trials were open label or did not provide information on blinding, and 8 trials did not adequately randomize participants or had unclear randomization methods. Other methodological limitations included inadequate allocation concealment methods (79% of trials) and between-group baseline differences (21% of trials).

The systematic review found fluoride varnish associated with a DMFS/DFS-prevented fraction of 0.43 (95% CI, 0.30-0.57) at 1 to 4.5 years (14 trials; n = 3419), although statistical heterogeneity was present (I2 = 75%). There were no statistically significant interactions between baseline caries severity, background fluoride exposure, varnish concentration, follow-up duration, application frequency, time since permanent teeth eruption, or control type and effects of varnish. Findings were similar when using the DMFT/DFT prevented fraction (0.44 [95% CI, 0.11-0.76]; I2 = 86%), which was reported in 5 trials (n = 3902). One subsequent fair-quality cluster randomized trial83 of 6- and 7-year-old children in rural China (n = 5397) reported results consistent with the systematic review (eTables 12 and 13 in the JAMA Supplement).83

Sealants

One good-quality systematic review20 (searches through August 2016) included 16 trials54,58,60-73 of a sealant vs no sealant (eTables 14 and 15 in the JAMA Supplement). Fifteen trials (n = 4195) evaluated a resin-based sealant, and 3 trials (n = 905 participants) evaluated a glass ionomer sealant (2 trials evaluated both types66,72). Children were aged 6 to 10 years at baseline in all trials but 1 (12-13 years).72 Baseline caries burden varied, and reporting of socioeconomic status and water fluoridation levels was suboptimal. Four trials were conducted in the US or Canada, 3 trials in China, 4 trials in Europe, and 1 trial each in Brazil, Colombia, New Zealand, and Thailand. Five trials were published between 2011 and 2014, 1 trial in 2005, and 10 trials between 1976 and 1995. In all trials, sealants were applied to occlusal surfaces of permanent premolar or molar teeth by dental professionals, except for 1 trial72 in which sealants were administered by dentists or schoolteachers with 3 days of training. The trials were unable to effectively mask outcome assessors because sealant materials are visible; other methodological limitations included unclear or inadequate randomization (33% of trials), unclear allocation concealment methods (37% of trials), and high or unclear attrition (at 48-54 months; 60% of trials).

The systematic review found resin-based sealants associated with decreased risk of carious first molars at 24 months among children aged 5 to 10 years (7 trials; n = 1322; odds ratio [OR], 0.12 [95% CI, 0.08-0.19]; I2 = 72%). Although statistical heterogeneity was present, estimates favored sealants in all trials (ORs ranged from 0.06 to 0.32). Based on the pooled estimate, the absolute risk difference ranged from 11% to 51%. Findings were similar at 36 months (7 trials; n = 1410; OR, 0.17 [95% CI, 0.11-0.27]; I2 = 90%) and at 48 to 54 months (4 trials; n = 440; OR, 0.21 [95% CI, 0.16- 0.28]; I2 = 45%); 1 trial (n = 120) reported decreased risk at longer term follow-up (OR at 9 years, 0.35 [95% CI, 0.22-0.55]).61 One trial (n = 671) found resin-based sealants compared with no treatment associated with slightly decreased change from baseline in DMFS index among older (12-13 years) children (mean difference, −0.24 [95% CI, −0.36 to −0.12]).72 Too few trials reported community water fluoridation levels to determine interaction with sealant effectiveness.

The systematic review found limited evidence on the effectiveness of glass ionomer sealants vs placebo, based on 2 trials with inconsistent findings (1 trial reported no benefit).66,72 In 1 of the trials, outcomes were very similar when sealants were administered by a dentist or a schoolteacher. Two subsequent, fair-quality trials84,85 (n = 187 and n = 50) also reported inconsistent findings for glass ionomer sealants vs no sealants (eTables 16 and 17 in the JAMA Supplement).

Silver Diamine Fluoride

One fair-quality trial (n = 452) evaluated SDF solution applied to primary canines and molars and occlusal surfaces of first permanent molars every 6 months vs no SDF for prevention of caries in 6-year-old schoolchildren in a setting with low community fluoridation (0.09 ppm F) and with high caries burden (mean DMFS, 3.6) in Cuba (eTables 18 and 19 in the JAMA Supplement).86 The trial report did not describe how persons who administer SDF were trained. At 36 months, SDF use was associated with fewer new active (decayed or filled) deciduous caries surfaces (mean, 0.3 vs 1.4; P < .001), fewer active first permanent molar surfaces (mean, 0.4 vs 1.1; P < .001), and decreased likelihood of experiencing at least 1 new decayed or filled tooth (26.1% vs 49.7%; relative risk, 0.52 [95% CI, 0.40-0.70]).

Xylitol

Two fair-quality cluster-randomized trials15,16 (n = 432 and n = 496) evaluated xylitol vs no xylitol in children 5 years or older (eTables 20 and 21 in the JAMA Supplement). Xylitol was administered in supervised school settings; in 1 trial, parents also administered xylitol when children were at home.16 One trial was open-label;15 neither trial adjusted for clustering, and both trials had unclear randomization methods.

One trial15 enrolled 10-year-old children (n = 496) in Finland in an area with natural water fluoridation and low baseline caries burden. It found xylitol lozenges for 1 or 2 years associated with similar effects on caries burden at 4 years vs no xylitol based on the D3MFS (DMFS with caries lesions extending into the dentin) increment (mean, 3.02 for xylitol for 2 years vs 2.74 for no xylitol; P > .05) or likelihood of D3MFS greater than 0 (vs placebo; adjusted OR, 1.01 [95% CI,0.40-2.56]), although estimates were imprecise. Another cluster-randomized trial (n = 432)16 evaluated children (mean age, 11.6 years) with high baseline caries burden (mean DMFS, 13.2-15.3) in a nonfluoridated setting in Lithuania. The trial found no difference between 5-times-daily use of xylitol gum vs placebo (nonxylitol gum in DMFS increment [all stages] at 3 years; mean, 8.1 vs 8.3; P > .05). However, xylitol gum was associated with decreased DMFS increment vs no gum (mean, 8.1 vs 12.4; P < .05). Xylitol and placebo gum were also associated with similar likelihood of experiencing a DMFS increment of 14 or greater.

Key Question 5. What are the harms of specific interventions (behavioral counseling, referral, and preventive interventions) to prevent oral health issues?

Evidence on harms of oral health preventive interventions was very limited. One trial of fluoride supplements (n = 349) reported no adverse events.79 None of 26 trials of fluoride gels included in a good-quality systematic review18 reported on tooth surface staining. Two trials in the systematic review reported on acute toxicity (nausea, gagging, or vomiting), with 1 trial reporting no events and a pooled analysis finding no difference between gel vs placebo or no treatment (n = 490; absolute risk difference, 0.01 [95% CI −0.01 to 0.02]; I2 = 0%).30,38 The systematic review also found no difference between fluoride gel vs placebo in risk of study withdrawal (19 trials; n = 8695; relative risk, 1.03 [95% CI, 0.89-1.19]).

For fluoride varnish, 5 of 16 trials included in a good-quality systematic review19 reported adverse events. Four trials46,54,56,58 (n = 1704) reported no adverse events, and 1 trial55 (n = 2967) reported 12 of 1473 children assigned to varnish reported adverse events (the most common adverse event was nausea, occurring in 7 children). All adverse events were described as self-limited, although 4 children were withdrawn due to mild adverse events. One subsequent trial of varnish (n = 5397) reported no adverse events.83

Only 354,61,67 of 16 trials of sealants vs no sealants included in a good-quality systematic review20 reported harms. All (n = 775) evaluated a resin-based sealant and reported no adverse events. One trial (n = 452) found SDF associated with increased likelihood of black-stained in active caries in deciduous teeth (97% vs 48%, P < .001) and in first permanent molars (86% vs 67%, P < .001),86 and 1 trial (n = 296) of xylitol reported 1 withdrawal due to diarrhea.15

Return to Table of Contents

The Table summarizes the evidence reviewed for this report. Evidence on screening was limited to 1 study74 that found oral health visual screening by a trained nurse associated with high sensitivity and specificity for untreated caries and a parent- or guardian-reported questionnaire associated with moderate sensitivity and high specificity.

Several oral health preventive interventions improved caries outcomes when administered in school or dental settings. Supervised administration of fluoride supplements in school was associated with a small decrease in the DMFT/DFT increment (mean difference, <1 affected tooth) in settings with low socioeconomic status, nonfluoridated water, or high caries burden. Fluoride gels, fluoride varnish, and sealants were each associated with improved caries outcomes when administered in schools or in dental clinics. Gels were administered by dental professionals or were self-administered with supervision by a dental or nondental professional; varnish and sealants were administered by dental professionals. The reduction in caries burden was larger for varnish19 than for gels,18 and resin-based sealants were associated with a strong reduction in the likelihood of developing carious first molars.20 Evidence on SDF for prevention was limited to a single trial86 suggesting benefit in a setting with high baseline caries burden and with inadequate water fluoridation. Two fair-quality trials of xylitol either found no benefit of xylitol (vs no xylitol15) or reported results that varied depending on the control type (large benefit vs no gum but no benefit vs placebo gum16).

Evidence on the effectiveness of interventions administered in the home or primary care setting was lacking because few trials of limited quality were available. There were no eligible trials of primary care counseling or referral to a dental professional. Trials of preventive interventions did not evaluate health outcomes (eg, quality of life or function), and factors that could potentially affect the effectiveness of oral health preventive interventions—such as water fluoridation levels, provision of oral health education, and oral health behaviors—were not consistently reported.

The harms of preventive interventions were sparsely reported, although serious harms were not described. As reported in trials of SDF for arresting caries,99 the single trial86 of SDF for prevention reported increased risk of black staining of inactive caries lesions. No study evaluated the association between exposure to fluoride via oral health preventive interventions in children older than 5 years and adolescents and risk of fluorosis. Studies of fluorosis risk have focused on younger children, who are at increased risk due to being at earlier stages of enamel and neurocognitive development.11,12

Limitations

This review had several limitations. First, non–English-language articles were excluded. However, non–English-language articles likely to affect conclusions were not identified. Second, the review did not search for studies published only as abstracts and did not formally assess for publication bias with graphical or statistical methods for small sample effects when conducting meta-analysis, due to small numbers of studies with serious methodological limitations.17 Third, previously published systematic reviews were used, rather than relying exclusively on primary studies. However, the systematic reviews were assessed as good-quality, and review findings were supplemented with subsequently published primary studies.100 Fourth, the review did not evaluate the effectiveness of tooth brushing or flossing, as these are routinely recommended and performed outside the primary care setting. Rather, the review addressed the effectiveness of oral health counseling, which includes counseling on tooth brushing, flossing, and diet. Fifth, meta-analyses had substantial statistical heterogeneity. To address statistical heterogeneity, random-effects models were used and stratified analyses on study-level factors were examined for potential sources. Sixth, poor-quality trials of xylitol were included, due to few higher-quality studies. However, xylitol conclusions were based on fair-quality trials. Seventh, few trials of preventive interventions have been published since 2000, potentially reducing applicability to current US practice.

Of note, all trials evaluated oral health preventive interventions administered by dental health professionals or in supervised school settings, with unknown effectiveness and feasibility in primary care. Barriers to provision of oral health preventive interventions in primary care include uncertain acceptability and uptake; potential need for additional training and equipment (particularly for sealants); and uncertain reimbursement. Some evidence indicates increased uptake in 2018 compared with 2008 of primary care administration of fluoride varnish in children younger than 5 years, suggesting feasibility for older children and adolescents,101 and limited evidence indicates that applying SDF in primary care settings is feasible.102

Return to Table of Contents

Administration of fluoride supplements, fluoride gels, varnish, and sealants in dental or school settings improved caries outcomes. Research is needed on the effectiveness of oral health preventive interventions in primary care settings and to determine the benefits and harms of screening.

Return to Table of Contents

Source: This article was published online in JAMA on November 7, 2023 (JAMA. 2023;330(17):1674-1686. doi:10.1001/jama.2023.20).

Conflict of Interest Disclosures: None reported.

Funding/Support: This research was funded under contract 75Q80120D00006, Task Order 75Q80121F32009, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.

Role of the Funder/Sponsor: Investigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions for this review. AHRQ had no role in study selection, quality assessment, or synthesis. AHRQ staff provided project oversight, reviewed the report to ensure that the analysis met methodological standards, and distributed the draft for peer review. Otherwise, AHRQ had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The opinions expressed in this document are those of the authors and do not reflect the official position of AHRQ or the US Department of Health and Human Services.

Additional Contributions: We gratefully acknowledge the AHRQ Medical Officer (Sheena Harris, MD, MPH). The USPSTF members, expert consultants, peer reviewers, and federal partner reviewers did not receive financial compensation for their contributions.

Additional Information: A draft version of this evidence report underwent external peer review from 5 content experts (Steven Levy, DDS, MPH [Department of Preventive and Community Dentistry, College of Dentistry, University of Iowa]; Charlotte Lewis, MD, MPH [Seattle Children’s, University of Washington]; Robert Weyant, MD, MDM, DrPH [Department of Dental Public Health, University of Pittsburgh School of Dental Medicine]; Christine Riedy, PhD, MPH [Oral Health Policy and Epidemiology, Delta Dental of Massachusetts; Department of Oral Public Health and Epidemiology, Harvard School of Dental Medicine; Center for Integration of Primary Care and Oral Health, Harvard University]; Richard Niederman, DMD [New York University College of Dentistry]) and 7 federal partner reviewers from the Centers for Disease Control and Prevention (1 reviewer), the National Institute of Child Health and Human Development (3 reviewers), and the National Institute of Dental and Craniofacial Research (3 reviewers). Comments from reviewers were presented to the USPSTF during its deliberation of the evidence and were considered in preparing the final evidence review.

Return to Table of Contents

1. Oral health surveillance report: trends in dental caries and sealants, tooth retention, and edentulism, United States, 1999-2004 to 2011-2016. Centers for Disease Control and Prevention. Published 2019. Accessed July 28, 2023. https://www.cdc.gov/oralhealth/publications/OHSR-2019-index.html
2. Basics of oral health. Centers for Disease Control and Prevention. Accessed September 26, 2023. https://www.cdc.gov/oralhealth/basics/index.htm
3. Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health challenge. Lancet. 2019;394(10194):249-260. doi:10.1016/S0140-6736(19)31146
4. Dye BA. The global burden of oral disease: research and public health significance. J Dent Res. 2017;96(4):361-363. doi:10.1177/0022034517693567
5. Naavaal S, Griffin SO, Jones JA. Impact of making dental care affordable on quality of life in adults aged 45 years and older. J Aging Health. 2020;32(7-8):861-870. doi:10.1177/0898264319857967
6. National Institutes of Health. Oral Health in America: Advances and Challenges. US Department of Health and Human Services, National Institute of Dental and Craniofacial Research; 2021.
7. Disparities in oral health. Centers for Disease Control and Prevention. Accessed September 26, 2023. https://www.cdc.gov/oralhealth/oral_health_disparities/index.htm
8. Guide to Community Preventive Services: CPSTF findings for oral health. Community Preventive Services Task Force. Published 2019. Accessed September 20, 2023. https://www.thecommunityguide.org/pages/task-force-findingsoral-health.htm
9. Chou R, Selph S, Bougatsos C, et al. Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Adults: A Systematic Review for the U.S. Preventive Services Task Force. Evidence Synthesis No 233. Agency for Healthcare Research and Quality; 2023. AHRQ Publication No. 23-05305-EF-1.
10. Final recommendation statement: oral cancer screening. US Preventive Services Task Force. Published 2013. Accessed October 30, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening
11. Chou R, Pappas M, Dana T, et al. Screening and interventions to prevent dental caries in children younger than 5 years: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;326(21):2179-2192. doi:10.1001/jama.2021.15658
12. Chou R, Pappas M, Dana T, et al. Screening and Interventions to Prevent Dental Caries in Children Younger Than Age Five Years: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 210. Agency for Healthcare Research and Quality; 2021. AHRQ publication 21-05279-EF-1. Accessed July 28, 2023.
13. Chou R, Bougatsos C, Griffin J, et al. Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Children and Adolescents Ages 5 to 17 Years: A Systematic Review for the U.S. Preventive Services Task Force. Evidence Synthesis No 232. Agency for Healthcare Research and Quality; 2023. AHRQ Publication 23-05304-EF-1.
14. U.S. Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published May 2021. Accessed July 28, 2023. https://uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual
15. Lenkkeri AM, Pienihäkkinen K, Hurme S, Alanen P. The caries-preventive effect of xylitol/maltitol and erythritol/maltitol lozenges: results of a double-blinded, cluster-randomized clinical trial in an area of natural fluoridation. Int J Paediatr Dent. 2012;22(3):180-190. doi:10.1111/j.1365-263X.2011.01182.x
16. Machiulskiene V, Nyvad B, Baelum V. Caries preventive effect of sugar-substituted chewing gum. Community Dent Oral Epidemiol. 2001;29(4):278-288. doi:10.1034/j.1600-0528.2001.290407.x
17. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
18. Marinho VC, Worthington HV, Walsh T, Chong LY. Fluoride gels for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2015;2015(6):CD002280. doi:10.1002/14651858.CD002280.pub2
19. Marinho VC, Worthington HV, Walsh T, Clarkson JE. Fluoride varnishes for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2013;(7):CD002279. doi:10.1002/14651858.CD002279.pub2
20. Ahovuo-Saloranta A, Forss H, Walsh T, et al. Pit and fissure sealants for preventing dental decay in permanent teeth. Cochrane Database Syst Rev. 2017;(7):CD001830. doi:10.1002/14651858.CD001830.pub5
21. Abadia SMS. Prevenção da cárie dentária através da aplicação tópica de gel de flúor fosfato ácido, utilizando-se isolamentorelativo e absoluto. Dissertation. Universidade de São Paulo; 1978.
22. Bijella MFTB. Prevenção da cárie dentária através da aplicação tópica de gel e solução de fuor fosfato acidulado come sem profilaxia prévia. Dissertation. Universidadede São Paulo; 1981.
23. Bryan ET, Williams JE. The cariostatic effectiveness of a phosphate-fluoride gel administered annually to school children; final results. J Public Health Dent. 1970;30(1):13-16. doi:10.1111/j.1752-7325.1970.tb00531.x
24. Cobb HB, Rozier RG, Bawden JW. A clinical study of the caries preventive effects of an APF solution and APF thixotropic gel. Pediatr Dent. 1980;2(4):263-266.
25. Cons NC, Janerich DT, Senning RS. Albany topical fluoride study. J Am Dent Assoc. 1970;80(4):777-781. doi:10.14219/jada.archive.1970.0113
26. DePaola PF, Soparkar M, Van Leeuwen M, DeVelis R. The anticaries effect of single and combined topical fluoride systems in school children. Arch Oral Biol. 1980;25(10):649-653. doi:10.1016/0003-9969(80)90095-3
27. Englander HR, Keyes PH, Gestwicki M, Sultz HA. Clinical anticaries effect of repeated topical sodium fluoride applications by mouthpieces. J Am Dent Assoc. 1967;75(3):638-644. doi:10.14219/jada.archive.1967.0266
28. Englander HR, Sherrill LT, Miller BG, Carlos JP, Mellberg JR, Senning RS. Incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluoridated water. J Am Dent Assoc. 1971;82(2):354-358. doi:10.14219/jada.archive.1971.0042
29. Gisselsson H, Birkhed D, Emilson CG. Effect of professional flossing with NaF or SnF2 gel on approximal caries in 13-16-year-old schoolchildren. Acta Odontol Scand. 1999;57(2):121-125. doi:10.1080/000163599429020
30. Hagan PP, Rozier RG, Bawden JW. The caries-preventive effects of full- and half-strength topical acidulated phosphate fluoride. Pediatr Dent. 1985;7(3):185-191
31. Heifetz SB, Horowitz HS, Driscoll WS. Two-year evaluation of a self-administered procedure for the topical application of acidulated phosphate-fluoride; final report. J Public Health Dent. 1970;30(1):7-12. doi:10.1111/j.1752-7325.1970.tb00530.x
32. Horowitz HS, Doyle J. The effect on dental caries of topically applied acidulated phosphate-fluoride: results after three years. J Am Dent Assoc. 1971;82(2):359-365. doi:10.14219/jada.archive.1971.006
33. Horowitz HS, Heifetz SB, McClendon BJ, Viegas AR, Guimaraes LO, Lopes ES. Evaluation of self-administered prophylaxis and supervised toothbrushing with acidulated phosphate fluoride. Caries Res. 1974;8(1):39-51. doi:10.1159/000260092
34. Ingraham RQ, Williams JE. An evaluation of the utility of application and cariostatic effectiveness of phosphate-fluorides in solution and gel states. J Tenn State Dent Assoc. 1970;50(1):5-12.
35. Jiang H, Tai B, Du M, Peng B. Effect of professional application of APF foam on caries reduction in permanent first molars in 6-7-year-old children: 24-month clinical trial. J Dent. 2005;33(6):469-473. doi:10.1016/j.jdent.2004.10.023
36. Mainwaring PJ, Naylor MN. A three-year clinical study to determine the separate and combined caries-inhibiting effects of sodium monofluorophosphate toothpaste and an acidulated phosphate-fluoride gel. Caries Res. 1978;12(4):202-212. doi:10.1159/000260334
37. Marthaler TM, König KG, Mühlemann HR. The effect of a fluoride gel used for supervised toothbrushing 15 or 30 times per year. Helv Odontol Acta. 1970;14(2):67-77.
38. Mestrinho HD, Bijella M, Bijella VT, et al. Prevention of dental caries through topical application of APF gel with plastic trays. Odontólogo Moderno. 1983;10(1-2):29-32.
39. Olivier M, Brodeur JM, Simard PL. Efficacy of APF treatments without prior toothcleaning targeted to high-risk children. Community Dent Oral Epidemiol. 1992;20(1):38-42. doi:10.1111/j.1600-0528.1992.tb00671.x
40. Ran F, Gedalia I, Fried M, Hadani P, Tved A. Effectiveness of fortnightly tooth brushing with amine fluorides in caries-prone subjects. J Oral Rehabil. 1991;18(4):311-316. doi:10.1111/j.1365-2842. 1991.tb00062.x
41. Shern RJ, Duany LF, Senning RS, Zinner DD. Clinical study of an amine fluoride gel and acidulated phosphate fluoride gel. Community Dent Oral Epidemiol. 1976;4(4):133-136. doi:10.1111/j.1600-0528.1976.tb00968.x-i1
42. Szwejda LF. Fluorides in community programs; a study of four years of various fluorides applied topically to the teeth of children in fluoridated communities. J Public Health Dent. 1972;32(1):25-33. doi:10.1111/j.1752-7325.1972.tb03938.x
43. Trubman A, Crellin JA. Effect on dental caries of self-application of acidulated phosphate fluoride paste and gel. J Am Dent Assoc. 1973;86(1):153-157. doi:10.1016/S0002-8177(73)61038-0
44. Truin GJ, van ‘t Hof MA. Professionally applied fluoride gel in low-caries 10.5-year-olds. J Dent Res. 2005;84(5):418-421. doi:10.1177/154405910508400504
45. van Rijkom HM, Truin GJ, van’t Hof MA. Caries-inhibiting effect of professional fluoride gel application in low-caries children initially aged 4.5-6.5 years. Caries Res. 2004;38(2):115-123. doi:10.1159/000075935
46. Arruda AO, Senthamarai Kannan R, Inglehart MR, Rezende CT, Sohn W. Effect of 5% fluoride varnish application on caries among school children in rural Brazil: a randomized controlled trial. Community Dent Oral Epidemiol. 2012;40(3):267-276. doi:10.1111/j.1600-0528.2011.00656.x
47. Borutta A, Künzel W, Rübsam F. The caries-protective efficacy of 2 fluoride varnishes in a 2-year controlled clinical trial. Article in German. Dtsch Zahn Mund Kieferheilkd Zentralbl. 1991;79(7):543-549.
48. Bravo M, Baca P, Llodra JC, Osorio E. A 24-month study comparing sealant and fluoride varnish in caries reduction on different permanent first molar surfaces. J Public Health Dent. 1997;57(3):184-186. doi:10.1111/j.1752-7325.1997.tb02972.x
49. Clark DC, Stamm JW, Robert G, Tessier C. Results of a 32-month fluoride varnish study in Sherbrooke and Lac-Megantic, Canada. J Am Dent Assoc. 1985;111(6):949-953. doi:10.14219/jada.archive.1985.0211
50. Gugwad SC, Shah P, Lodaya R, et al. Caries prevention effect of intensive application of sodium fluoride varnish in molars in children between age 6 and 7 years. J Contemp Dent Pract. 2011;12(6):408-413. doi:10.5005/jp-journals-10024-1068
51. Hardman MC, Davies GM, Duxbury JT, Davies RM. A cluster randomised controlled trial to evaluate the effectiveness of fluoride varnish as a public health measure to reduce caries in children. Caries Res. 2007;41(5):371-376. doi:10.1159/000104795
52. Holm GB, Holst K, Mejàre I. The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar. Acta Odontol Scand. 1984;42(4):193-197. doi:10.3109/ 00016358408993871
53. Koch G, Petersson LG. Caries preventive effect of a fluoride-containing varnish (Duraphat) after 1 year’s study. Community Dent Oral Epidemiol. 1975;3(6):262-266. doi:10.1111/j.1600-0528.1975.tb00321.x
54. Liu BY, Lo EC, Chu CH, Lin HC. Randomized trial on fluorides and sealants for fissure caries prevention. J Dent Res. 2012;91(8):753-758. doi:10.1177/0022034512452278
55. Milsom KM, Blinkhorn AS,Walsh T, et al. A cluster-randomized controlled trial: fluoride varnish in school children. J Dent Res. 2011;90(11):1306-1311. doi:10.1177/0022034511422063
56. Moberg Sköld U, Petersson LG, Lith A, Birkhed D. Effect of school-based fluoride varnish programmes on approximal caries in adolescents from different caries risk areas. Caries Res. 2005;39(4):273-279. doi:10.1159/000084833
57. Modéer T, Twetman S, Bergstrand F. Three-year study of the effect of fluoride varnish (Duraphat) on proximal caries progression in teenagers. Scand J Dent Res. 1984;92(5):400-407. doi:10.1111/j.1600-0722.1984.tb00908.x
58. Tagliaferro EP, Pardi V, Ambrosano GM, Meneghim M de C, da Silva SR, Pereira AC. Occlusal caries prevention in high and low risk schoolchildren: a clinical trial. Am J Dent. 2011;24(2):109-114.
59. Tewari A, Chawla HS, Utreja A. Comparative evaluation of the role of NaF, APF & Duraphat topical fluoride applications in the prevention of dental caries—a 2 1/2 years study. J Indian Soc Pedod Prev Dent. 1991;8(1):28-35.
60. Bojanini J, Garces H, McCune RJ, Pineda A. Effectiveness of pit and fissure sealants in the prevention of caries. J Prev Dent. 1976;3(6):31-34.
61. Bravo M, Montero J, Bravo JJ, Baca P, Llodra JC. Sealant and fluoride varnish in caries: a randomized trial. J Dent Res. 2005;84(12):1138-1143. doi:10.1177/ 154405910508401209
62. Brooks JD, Mertz-Fairhurst EJ, Della-Giustina VE, Williams JE, Fairhurst CW. A comparative study of two pit and fissure sealants: two-year results in Augusta, Ga. J Am Dent Assoc. 1979;98(5):722-725. doi:10.14219/jada.archive.1979.0149
63. Charbeneau GT, Dennison JB. Clinical success and potential failure after single application of a pit and fissure sealant: a four-year report. J Am Dent Assoc. 1979;98(4):559-564. doi:10.14219/jada.archive.1979.0112
64. Erdogan B, Alaçam T. Evaluation of a chemically polymerized pit and fissure sealant: results after 4.5 years. J Paediatr Dent. 1987;3:11-13.
65. Hunter PB. A study of pit and fissure sealing in the School Dental Service. NZ Dent J. 1988;84(375):10-12.
66. Liu Y, Rong W, Zhao X, et al. Caries prevention effect of resin based sealants and glass ionomer sealants. Article in Chinese. Zhonghua Kou Qiang Yi Xue Za Zhi. 2014;49(4):199-203.
67. Muller-Bolla M, Lupi-Pégurier L, Bardakjian H, Velly AM. Effectiveness of school-based dental sealant programs among children from low-income backgrounds in France: a pragmatic randomized clinical trial. Community Dent Oral Epidemiol. 2013;41(3):232-241. doi:10.1111/cdoe.12011
68. Reisbick MH, Thanos CE, Berson RB, Goldstein CM. Benefit from sealants in a moderately fluoridated community. CDA J. 1982;10(1):53-56.
69. Richardson AS, Waldman R, Gibson GB, Vancouver BC. The effectiveness of a chemically polymerized sealant in preventing occlusal caries: two year results. Dent J. 1978;44(6):269-272.
70. Rock WP, Gordon PH, Bradnock G. The effect of operator variability and patient age on the retention of fissure sealant resin. Br Dent J. 1978;145(3):72-75. doi:10.1038/sj.bdj.4804121
71. Sheykholeslam Z, Houpt M. Clinical effectiveness of an autopolymerized fissure sealant after 2 years. Community Dent Oral Epidemiol. 1978;6(4):181-184. doi:10.1111/j.1600-0528.1978.tb01146.x
72. Songpaisan Y, Bratthall D, Phantumvanit P, Somridhivej Y. Effects of glass ionomer cement, resin-based pit and fissure sealant and HF applications on occlusal caries in a developing country field trial. Community Dent Oral Epidemiol. 1995;23(1):25-29. doi:10.1111/j.1600-0528.1995.tb00193.x
73. Tang LH, Shi L, Yuan S, et al. Effectiveness of 3 different methods in prevention of dental caries in permanent teeth among children. Article in Chinese. Shanghai Kou Qiang Yi Xue. 2014;23(6): 736-739.
74. Beltrán ED, Malvitz DM, Eklund SA. Validity of twomethods for assessing oral health status of populations. J Public Health Dent. 1997;57(4):206- 214. doi:10.1111/j.1752-7325.1997.tb02977.x
75. Aasenden R, DePaola PF, Brudevold F. Effects of daily rinsing and ingestion of fluoride solutions upon dental caries and enamel fluoride. Arch Oral Bioll. 1972;17(12):1705-1714. doi:10.1016/0003-9969(72)90233-6
76. Blinkhorn AS, Downer MC, Mackie IC, Bleasdale RS. Evaluation of a practice based preventive programme for adolescents. Community Dent Oral Epidemiol. 1981;9(6):275-279. doi:10.1111/ j.1600-0528.1981.tb00345.x
77. DePaola PF, Lax M. The caries-inhibiting effect of acidulated phosphate-fluoride chewable tablets: a two-year double-blind study. J Am Dent Assoc. 1968;76(3):554-557. doi:10.14219/jada.archive.1968.0065
78. Driscoll WS, Heifetz SB, Korts DC. Effect of acidulated phosphate-fluoride chewable tablets on dental caries in schoolchildren: results after 30 months. J Am Dent Assoc. 1974;89(1):115-120. doi:10.14219/jada.archive.1974.0338
79. Liu HY, Hung HC, Hsiao SY, et al. Impact of 24-month fluoride tablet program on children with disabilities in a non-fluoridated country. Res Dev Disabil. 2013;34(9):2598-2605. doi:10.1016/j.ridd. 2013.05.006
80. O’Rourke CA, Attrill M, Holloway PJ. Cost appraisal of a fluoride tablet programme to Manchester primary schoolchildren. Community Dent Oral Epidemiol. 1988;16(6):341-344. doi:10.1111/j.1600-0528.1988.tb00578.x
81. Stephen KW, Campbell D. Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at school: a double-blind trial. Br Dent J. 1978;144(7):202-206. doi:10.1038/sj.bdj.4804066
82. Rim KH, Jong MC, Hwang CJ, et al. Preventive effect of subacidic 1% NaF-HF gel on dental caries in 6- to 7-year-old schoolchildren: a randomized controlled trial. Quintessence Int. 2021;0(0):318-326. doi:10.3290/j.qi.b912653
83. Wang Z, Rong W, Xu T. Effect of fluoride varnish in caries prevention on permanent first molars: a 36-month cluster randomized controlled trial. Pediatr Dent. 2021;43(2):82-87.
84. Hesse D, Guglielmi CAB, Raggio DP, Bönecker MJS, Mendes FM, Bonifácio CC. A traumatic restorative treatment-sealed versus nonsealed first permanent molars: a 3-year split-mouth clinical trial. Caries Res. 2021;55(1):12-20. doi:10.1159/ 000506466
85. Uzel I, Gurlek C, Kuter B, Ertugrul F, Eden E. Caries-preventive effect and retention of glass-ionomer and resin-based sealants: a randomized clinical comparative evaluation. Biomed Res Int. 2022;2022:7205692. doi:10.1155/2022/7205692
86. Llodra JC, Rodriguez A, Ferrer B, Menardia V, Ramos T, Morato M. Efficacy of silver diamine fluoride for caries reduction in primary teeth and first permanent molars of schoolchildren: 36-month clinical trial. J Dent Res. 2005;84(8):721-724. doi:10.1177/154405910508400807
87. Alanen P, Isokangas P, Gutmann K. Xylitol candies in caries prevention: results of a field study in Estonian children. Community Dent Oral Epidemiol. 2000;28(3):218-224. doi:10.1034/j.1600-0528. 2000.280308.x
88. Isokangas P, Alanen P, Tiekso J, Makinen KK. Xylitol chewing gum in caries prevention: a field study in children. J Am Dent Assoc. 1988;117(2):315-320. doi:10.1016/S0002-8177(88)72017-6
89. Kandelman D, Gagnon G. A 24-month clinical study of the incidence and progression of dental caries in relation to consumption of chewing gum containing xylitol in school preventive programs. J Dent Res. 1990;69(11):1771-1775. doi:10.1177/00220345900690111201
90. Lee W, Spiekerman C, Heima M, et al. The effectiveness of xylitol in a school-based cluster-randomized clinical trial. Caries Res. 2015;49(1):41-49. doi:10.1159/000360869
91. Scheinin A, Bánóczy J. Xylitol and caries: the collaborative WHO oral disease preventive programme in Hungary. Int Dent J. 1985;35(1):50-57.
92. Honkala E, Honkala S, Shyama M, Al-Mutawa SA. Field trial on caries prevention with xylitol candies among disabled school students. Caries Res. 2006;40(6):508-513. doi:10.1159/000095650
93. Kandelman D, Bär A, Hefti A. Collaborative WHO xylitol field study in French Polynesia, I: baseline prevalence and 32-month caries increment. Caries Res. 1988;22(1):55-62. doi:10.1159/000261084
94. Mäkinen KK, Bennett CA, Hujoel PP, et al. Xylitol chewing gums and caries rates: a 40-month cohort study. J Dent Res. 1995;74(12):1904-1913. doi:10.1177/00220345950740121501
95. Driscoll WS, Heifetz SB, Korts DC. Effect of chewable fluoride tablets on dental caries in schoolchildren: results after six years of use. J Am Dent Assoc. 1978;97(5):820-824. doi:10.14219/jada.archive.1978.0402
96. Muller-Bolla M, Pierre A, Lupi-Pégurier L, Velly AM. Effectiveness of school-based dental sealant programs among children from low-income backgrounds: a pragmatic randomized clinical trial with a follow-up of 3 years. Community Dent Oral Epidemiol. 2016;44(5):504-511. doi:10.1111/cdoe.12241
97. Scheinin A, Bánóczy J, Szöke J, et al. Collaborative WHO xylitol field studies in Hungary, I: three-year caries activity in institutionalized children. Acta Odontol Scand. 1985;43(6):327-347. doi:10.3109/00016358509046517
98. Scheinin A, Pienihäkkinen K, Tiekso J, et al. Collaborative WHO xylitol field studies in Hungary, VII: two-year caries incidence in 976 institutionalized children. Acta Odontol Scand. 1985;43(6):381-387. doi:10.3109/00016358509046523
99. Gao SS, Zhao IS, Hiraishi N, et al. Clinical trials of silver diamine fluoride in arresting caries among children: a systematic review. JDR Clin Trans Res. 2016;1(3):201-210. doi:10.1177/2380084416661474
100. Whitlock EP, Lin JS, Chou R, Shekelle P, Robinson KA. Using existing systematic reviews in complex systematic reviews. Ann Intern Med. 2008;148(10):776-782. doi:10.7326/0003-4819-148-10-200805200-00010
101. Lewis C, Quinonez R, Sisk B, et al. Incorporating oral health into pediatric practice: national trends 2008, 2012, 2018. Acad Pediatr. 2022;22(8):1443-1451. doi:10.1016/j.acap.2022.06.008
102. Bernstein RS, Johnston B, Mackay K, Sanders J. Implementation of a primary care physician–led cavity clinic using silver diamine fluoride. J Public Health Dent. 2019;79(3):193-197. doi:10.1111/jphd.12331

Return to Table of Contents

The analytic framework depicts the relationship between the population, screening, interventions, outcomes, and potential harms of screening for oral health. The far left of the framework shows the target population for screening as children and adolescents ages 5 to 17 years at a clinician office visit. To the right of the population is an arrow corresponding to key question 2 which represents the accuracy of screening and risk factor assessment, identifying those at average or increased risk for oral health issues. This step may lead to harms, which corresponds to key question 3. Arrows show that children at either risk level with oral health issues may receive interventions, with the aim of decreased dental caries and tooth loss and improved quality of life, functional status, and morbidity. These outcomes are represented in a box at the end of the pathway. An overarching arrow representing key question 1 represents the effect of screening on these outcomes of interest.

Evidence reviews for the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety of a preventive service. The questions are depicted by linkages that relate interventions and outcomes. A dashed line depicts a health outcome that follows an intermediate outcome. For additional information, see the USPSTF Procedure Manual.14

 

Return to Table of Contents

The analytic framework depicts the relationship between the population, preventive interventions, outcomes, and potential harms of interventions to prevent oral health issues. The far left of the framework describes the target population as children and adolescents ages 5 to 17 years at a clinician office visit. To the right of the population is an arrow corresponding to key question 1 which represents accuracy of risk factor assessment, identifying those at average or increased risk for oral health issues. Arrows show that children at either risk level without oral health issues would receive preventive interventions of behavioral counseling, referral to a dental health care provider, and preventive intervention, representing key questions 2, 3, and 4 respectively, with the aim of decreased dental caries and tooth loss, and improved quality of life, functional status, and morbidity. These outcomes are represented in a box at the end of the pathway. Preventive interventions may lead to harms, which are represented by an arrow for key question 5.

Evidence reviews for the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety of a preventive service. The questions are depicted by linkages that relate interventions and outcomes. For additional information, see the USPSTF Procedure Manual.1
a This is the same as KQ2b from the screening analytic framework (Figure 1).

Return to Table of Contents

Figure 3 is a literature flow diagram depicting the search and selection of articles for the review. The figure shows that 8,677 citations were identified through literature database searches and other sources. Five hundred and thirty-one articles were reviewed at the full-text level after excluding 8,146 citations based on review of titles and abstracts. Four hundred and forty-eight full-text articles were excluded for the following reasons: Ineligible intervention: 127, Ineligible study design: 60, Ineligible population: 56, Publication used as source document to identify studies: 54, Ineligible outcome: 40, Ineligible comparison: 42, Not a study: 31, Study not in English: 10, Ineligible setting: 9, Ineligible criteria for SRs: 7, Poor quality: 4, Ineligible screener: 3, Ineligible country: 2, Abstract only: 2, Results not usable: 1. Twenty-three studies (in 27 publications) and 3 SRs were included that provided evidence for the KQs. A footnote describes that 54 trials were included in the SRs (in 53 publications). For the Screening framework, there was one study included for KQ2a on diagnostic accuracy for those with existing oral health issues. There were no studies included for KQs 1, 2b, or 3. For the Prevention framework, for KQ4 on Preventive Interventions, the following studies were included: Supplements: 7 trials (in 8 publications), Fluoride gel: 1 SR (26 trials, in 25 publications), 1 subsequent trial, Fluoride varnish: 1 SR (14 trials), 1 subsequent trial, Sealants: 1 SR (16 trials), 2 subsequent trials, 1 additional publication, SDF: 1 trial, Xylitol: 10 trials (in 12 publications). For KQ5 on Harms of Preventive Interventions, the following 13 studies were included: Supplements: 1 trial, Fluoride gel: 2 trials, Fluoride varnish: 6 trials, Sealants: 3 trials, SDF: 1 trial, Xylitol: 1 trial. There were no studies included for KQs 1, 2, or 3.

The sum of the number of studies per key question (KQ) exceeds the total number of studies because some studies were applicable to multiple KQs or systematic reviews. SDF indicates silver diamine fluoride.
a Fifty-four trials included in the systematic reviews (in 53 publications).

Return to Table of Contents

Objective/ intervention No. of studies; study design
(No. of participants)
Summary of findings by outcome Consistency/precision;
Reporting bias
Overall quality Body of evidence limitations Strength of evidence Applicability
Screening KQ1: Screening effectiveness
  No studies NA NA NA

NA

NA NA
Screening KQ2: Screening accuracy
A. In persons who have oral health issues

B. In persons who are at increased risk for future oral health issues

A. 1 Cross-sectional study (n = 305)

B. No studies

Visual screen by registered nurse: sensitivity, 0.92 (95% CI, 0.84-0.97) and specificity, 0.993 (95% CI, 0.96-0.9998) or untreated caries

17-Item questionnaire: sensitivity, 0.69 (95% CI, 0.60-0.77) and specificity, 0.88 (95% CI, 0.83-0.93) for untreated caries

Unable to assess consistency (1 study)

Reasonably precise

Reporting bias not detected

Fair Single study with methodological limitations; results unvalidated Low Nurses received 5 h of training; questionnaire based on report by children’s parents or guardians; study conducted in rural setting with high prevalence of untreated caries (35%)
Screening KQ3: Screening harms
  No studies NA NA NA

NA

NA NA
Prevention KQ1: Screening accuracy (identification of persons at increased risk of future caries)a
  No studies NA NA NA

NA

NA NA
Prevention KQ2: Behavioral counseling
  No studies NA NA NA

NA

NA NA
Prevention KQ3: Referral
  No studies NA NA NA

NA

NA NA
Prevention KQ4: Preventive interventions
Supplements 7 Trials (n = 3382) Fluoride supplements were associated with decreased DMFT/DFT increment at 1.5 y to 3 y (mean difference, −0.73 [95% CI, −1.30 to −0.19]; 6 trials) when administered in schools under supervision; however, the only trial in which fluoride supplements were administered at home reported low adherence and no benefit (mean difference, 0.13 [95% CI, −0.38 to 0.64]) Serious inconsistency

No imprecision

Reporting bias not suspected

Fair All trials had methodological limitations; substantial statistical heterogeneity Low Supplements administered in school under supervision in all trials except 1; all trials published prior to 1990 except for 1; no trial of adolescents and all trials but 1 focused on children aged <10 y; trials conducted in settings with high caries burden, low SES, or low fluoridation levels; 6 trials conducted in the US or UK and 1 trial conducted in Taiwan
Fluoride gel 1 Systematic review (26 trials [n=8619]) and 1 subsequent RCT (n=986) Systematic review found fluoride gels associated a DMFT/DFT prevented fraction at outcomes closest to 3 y of 0.32 (95% CI, 0.19-0.46; I2 = 91% [10 trials; n = 3198]); based on 4 placebo-controlled trials (n = 1525), the prevented fraction was 0.18 (95% CI, 0.09-0.27; I2 = 6%)

One subsequent trial reported consistent results

Consistent (based on placebo-controlled trials)

No imprecision

Reporting bias not suspected

Fair Most trials had methodological limitations; statistical heterogeneity when all (placebo-controlled and non–placebo-controlled) trials pooled; few placebo-controlled trials Moderate Eighteen trials conducted in the US, Europe, or Canada; only 1 trial focused on adolescents; gels were applied by dental professional or under supervision and applied in dental clinics or schools; limited reporting of water fluoridation levels and SES; most trials conducted in settings with high caries burden; 22 trials published prior to 1990
Fluoride varnish 1 Systematic review (14 trials [n = 6965]) and 1 subsequent RCT (n = 5397) Systematic review found fluoride varnish associated with a DMFS/DFS-prevented fraction of 0.43 (95% CI, 0.30-0.57; 14 trials); a DMFT/DFT-prevented fraction of 0.44 (95% CI, 0.11-0.76; 5 trials); and a reduced risk of developing ≥1 caries (RR, 0.75 [95% CI, 0.53-1.05]; I2 = 89.2%; 5 trials)

One subsequent trial reported results consistent with the systematic review

Some inconsistency present

No imprecision

Reporting bias not suspected

Fair Most trials had methodological limitations; statistical heterogeneity present Moderate Nine trials conducted in Europe (no trials conducted in the US); no trial focused on adolescents; varnish applied by dental professionals at school or in dental clinics; limited reporting of water fluoridation levels and SES; 7 trials published prior to 1998
Sealants Resin-based sealant: 1 systematic review (15 RCTs; n = 4195 children) and 1 supplemental RCT (n = 50 children)

Glass ionomer sealant: 1 systematic review (3 RCTs; n = 905) and 2 subsequent RCTs (n = 237)

Resin-based sealants: systematic review found resin-based sealants associated with decreased risk of carious first molars at 24 mo (7 trials; OR, 0.12 [95% CI, 0.08-0.19]), 36 mo (7 trials; OR, 0.17 [95% CI, 0.11-0.27]; I2 = 90%), and 48 to 54 mo (4 trials; OR, 0.21 [95% CI, 0.16-0.28]; I2 = 45%)

Glass ionomer sealants: systematic review (2 trials) and 1 subsequent trial found inconsistent effects of glass ionomer sealants vs no sealants on caries outcomes

Resin-based sealants:
   No inconsistency
   No imprecision

Glass ionomer sealants:
   Serious inconsistency
   Serious imprecision
   Reporting bias (all sealants) not suspected

Fair Open-label design; few trials of glass ionomer sealants Moderate Nine trials conducted in the US, Europe, Canada, or New Zealand; limited information on SES and fluoridation levels; higher caries burden settings; variability in sealants evaluated; 10 trials published prior to 1996; sealants applied by dental professionals
Silver diamine fluoride 1 RCT (n = 452) Silver diamine fluoride associated with fewer new surfaces with active caries in deciduous dentition (mean, 0.3 vs 1.4; P < .001) and first permanent molars (mean, 0.4 vs 1.1; P < .001), and decreased likelihood of ≥1 new decayed or filled teeth (26.1% vs 49.7%; RR, 0.52 [95% CI, 0.40-0.70]) Unable to assess consistency (1 trial)

No imprecision

Reporting bias not suspected

Fair One trial with methodological limitations Low Trial conducted in Cuba in a setting with high caries burden in children aged 6 y; training of person administering SDF not reported; children received oral health education and performed fluoride mouth rinses
Xylitol 10 Trials (n = 4267) One fair-quality trial found no difference between xylitol vs no xylitol in caries outcomes at 4 y, and 1 fair-quality trial found no difference between xylitol vs placebo in DMFS increment at 3 y but a decreased DMFS increment vs no xylitol

Eight other trials found xylitol associated with reduced DMFS increment vs no xylitol (mean difference, −2.38 [95% CI, −3.66 to −1.15]), but had serious methodological imitations and were rated poor-quality

Some inconsistency

No imprecision

Reporting bias not suspected

Fair (based on fair-quality trials) Only 2 fair-quality trials; potential differences in outcomes based on control type Low Six trials conducted in Europe (no trials in the US); no trial focused on adolescents; xylitol administered under supervision at school in all trials except 1; 4 trials published in or prior to 1991; fluoride exposure varied; information on SES not provided
Prevention KQ5: Harms of preventive interventions
  Supplements: 1 trial (n = 349)

Gel: 2 trials (n = 490)

Varnish: 6 trials (n = 8574)

Sealants: 3 trials (n = 775)

SDF: 1 trial (n = 452)

Xylitol: 1 trial (n = 296)

Supplements: 1 trial reported no adverse events

Gels: no difference between gel vs placebo or no treatment in acute toxicity (nausea, gagging, or vomiting); absolute risk difference, 0.01 (95% CI, −0.01 to 0.02)

Varnish: 5 trials reported no adverse events and 1 trial reported 0.04% of children allocated to varnish reported a self-limited adverse event (most commonly nausea), with 4 withdrawals due to mild adverse events

Sealants: 3 trials of resin-based sealants reported no adverse events

SDF: SDF associated with increased likelihood of inactive caries and black stain in deciduous teeth (97% vs 48%, P < .001) and first permanent molars (86% vs 67%, P < .001)

Xylitol: 1 trial reported 1 withdrawal from xylitol due to diarrhea

Consistency uncertain, due to sparse data

Serious imprecision

Potential reporting bias, as few trials reported harms

Poor Few trials reported harms or harms reporting was suboptimal Low Evidence on harms was very sparse, limiting assessments of applicability

Abbreviations: DFS, decayed or filled surfaces; DFT, decayed or filled teeth; DMFS, decayed, missing, or filled surfaces; DMFT, decayed, missing, or filled teeth; KQ, key question; NA, not applicable; OR, odds ratio; RCT, randomized clinical trial; RR, relative risk; SDF, silver diamine fluoride; SES, socioeconomic status.
a This is the same as KQ2b from the screening framework.

Return to Table of Contents